Marty Tenenbaum is an e-commerce wizard in a dysfunctional drug-development world.
Now Tenenbaum, a metastatic melanoma survivor and chairman of the online high-tech link CommerceNet in Palo Alto, wants to adopt the Internet’s efficiencies to connect and manage virtual companies of drug researchers. He argues that “virtual pharmas” can shorten the time it takes to find out which drugs work — and which don’t — and cut the cost of health care.
Tenenbaum is setting up a company around that premise. He is reluctant to release details about the venture but issues an open invitation to “people who want to transform this industry.”
Yet anyone who doubts Tenenbaum should consider his resume: founder of Enterprise Integration Technologies, the first company to conduct a commercial Internet transaction, secure an online transaction and online auction. He co-founded Veo Systems and was an artificial intelligence researcher at SRI International and Schlumberger Ltd.